Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085209931> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W2085209931 endingPage "A547" @default.
- W2085209931 startingPage "A547" @default.
- W2085209931 abstract "Treatment with antipsychotic medication is an important element of relapse prevention in the management of schizophrenia and can reduce inpatient stays. Recently, the long-acting atypical antipsychotic paliperidone long-acting injectable (PLAI), a once-monthly LAI antipsychotic, was approved for treatment of schizophrenia in Germany. The study aims at estimating, based on a previously published model, the cost-effectiveness of paliperidone long-acting injections compared to other common antipsychotic treatment strategies in patients diagnosed with schizophrenia in Germany. A Markov decision analytic model was adapted to the German health care system. The model considers the cost-effectiveness for PLAI as a maintenance treatment for patients with schizophrenia from the payer perspective. The patients transition between eight health states on a monthly basis over a 5-year time horizon. As therapeutic strategies PLAI, quetiapine, risperidone long-acting injections (RLAI), oral olanzapine, oral risperidone, zuclopenthixol decanoate, olanzapine long-acting injections (OLAI), oral typical and oral atypical were compared. Probability of relapse, level of adherence, side effects and treatment discontinuation were derived from the Swedish original model. Input factors regarding resource use and costs were estimated and adjusted for the German health care system. A probabilistic sensitivity analyses using cost-effectiveness scatter plots was performed to visualize the robustness of the results. In base case scenario PLAI is superior to RLAI in gained quality adjusted life years (QALYs) and avoided relapses. Relative to all other treatment strategies PLAI is more effective with regard to gained QALYs and avoided relapses but results in higher treatment costs over a 5-year horizon in base case scenario. The results were tested in probabilistic sensitivity analyses PLAI dominates RLAI and compared to the other treatment strategies PLAI has shown to be more effective but results in higher costs in base case scenario." @default.
- W2085209931 created "2016-06-24" @default.
- W2085209931 creator A5001823062 @default.
- W2085209931 creator A5069767084 @default.
- W2085209931 creator A5088342461 @default.
- W2085209931 creator A5091517921 @default.
- W2085209931 date "2013-11-01" @default.
- W2085209931 modified "2023-10-08" @default.
- W2085209931 title "Cost-Effectiveness of Paliperidone Palmitate for the Treatment of Schizophrenia in Germany" @default.
- W2085209931 doi "https://doi.org/10.1016/j.jval.2013.08.1403" @default.
- W2085209931 hasPublicationYear "2013" @default.
- W2085209931 type Work @default.
- W2085209931 sameAs 2085209931 @default.
- W2085209931 citedByCount "0" @default.
- W2085209931 crossrefType "journal-article" @default.
- W2085209931 hasAuthorship W2085209931A5001823062 @default.
- W2085209931 hasAuthorship W2085209931A5069767084 @default.
- W2085209931 hasAuthorship W2085209931A5088342461 @default.
- W2085209931 hasAuthorship W2085209931A5091517921 @default.
- W2085209931 hasBestOaLocation W20852099311 @default.
- W2085209931 hasConcept C112930515 @default.
- W2085209931 hasConcept C118552586 @default.
- W2085209931 hasConcept C2776412080 @default.
- W2085209931 hasConcept C2776619155 @default.
- W2085209931 hasConcept C2776921671 @default.
- W2085209931 hasConcept C2777126507 @default.
- W2085209931 hasConcept C2778715236 @default.
- W2085209931 hasConcept C2780057945 @default.
- W2085209931 hasConcept C2780494398 @default.
- W2085209931 hasConcept C2780634440 @default.
- W2085209931 hasConcept C2781089641 @default.
- W2085209931 hasConcept C2908997079 @default.
- W2085209931 hasConcept C3019080777 @default.
- W2085209931 hasConcept C71924100 @default.
- W2085209931 hasConceptScore W2085209931C112930515 @default.
- W2085209931 hasConceptScore W2085209931C118552586 @default.
- W2085209931 hasConceptScore W2085209931C2776412080 @default.
- W2085209931 hasConceptScore W2085209931C2776619155 @default.
- W2085209931 hasConceptScore W2085209931C2776921671 @default.
- W2085209931 hasConceptScore W2085209931C2777126507 @default.
- W2085209931 hasConceptScore W2085209931C2778715236 @default.
- W2085209931 hasConceptScore W2085209931C2780057945 @default.
- W2085209931 hasConceptScore W2085209931C2780494398 @default.
- W2085209931 hasConceptScore W2085209931C2780634440 @default.
- W2085209931 hasConceptScore W2085209931C2781089641 @default.
- W2085209931 hasConceptScore W2085209931C2908997079 @default.
- W2085209931 hasConceptScore W2085209931C3019080777 @default.
- W2085209931 hasConceptScore W2085209931C71924100 @default.
- W2085209931 hasIssue "7" @default.
- W2085209931 hasLocation W20852099311 @default.
- W2085209931 hasOpenAccess W2085209931 @default.
- W2085209931 hasPrimaryLocation W20852099311 @default.
- W2085209931 hasRelatedWork W1585586667 @default.
- W2085209931 hasRelatedWork W2016058044 @default.
- W2085209931 hasRelatedWork W2025729658 @default.
- W2085209931 hasRelatedWork W2080975733 @default.
- W2085209931 hasRelatedWork W2085209931 @default.
- W2085209931 hasRelatedWork W2095138756 @default.
- W2085209931 hasRelatedWork W2132871355 @default.
- W2085209931 hasRelatedWork W2167116216 @default.
- W2085209931 hasRelatedWork W2180693160 @default.
- W2085209931 hasRelatedWork W2549002080 @default.
- W2085209931 hasVolume "16" @default.
- W2085209931 isParatext "false" @default.
- W2085209931 isRetracted "false" @default.
- W2085209931 magId "2085209931" @default.
- W2085209931 workType "article" @default.